Top Choice for Breast CA Is Aromatase Inhibitor (CME/CE)

posted on Jul 15 by MedPage Today OB/Gyn in the Uncategorized category Aromatase inhibitor therapy should be considered for all postmenopausal women with hormone receptor-positive breast cancers, the American Society of Clinical Oncology re-emphasized.